FDA Inspections

Week of October 21st 2018 | FDA Sent These Warning Letters to Pharma Companies

FDA posted 10 warning letters this week: 8 of them citing unapproved or misbranded new drugs with problematic websites as the source of FDA’s information. Along with this, 1 warning letter was published that was issued to a compounding pharmacy.

3 Quick (but Proven) CMO Tips you Missed at the PDA Event

Every day I work with companies that are looking to find innovative solutions that mitigate compliance risk. I was invited to PDA Midwest's Risk Mitigation & Sterility Assurance Event to share what FDAzilla has found the best practices in supply chain risk mitigation are. In case you missed it, here they are.